Literature DB >> 2463569

Pediatric transvenous pacing: a concern for venous thrombosis?

P C Gillette1, V Zeigler, G B Bradham, P Kinsella.   

Abstract

Transvenous pacing has become the preferred method of pediatric cardiac pacing. Although no clinically important venous thromboses have been reported, concern has arisen about occult venous thrombosis. We evaluated 19 randomly selected children who had transvenous pacing implants. Sixteen were evaluated by venous plethysmography and Doppler while three had venous angiography and one had both. The leads had all been inserted by subclavian vein puncture. Ages at time of implant ranged from 17 months to 25 years; mean 9.8 years, median 9.0 years. Implant weights were from 9.6 kg to 56.0 kg, mean 31 kg, median 31 kg. The interval from implant to time of procedure ranged from 1 month to 46 months, mean 22.5 months, median 24 months. Four patients had one lead while 14 had two and one had four. Eleven leads were unipolar and 25 were bipolar. The bipolar leads were 6.6 French diameter. In the 19 patients evaluated, no thromboses were detected nor any narrowing greater than 10% of proximal diameter as seen by angiography. No disturbances of blood flow in the subclavian vein was noted. Transvenous pacing did not result in venous flow abnormalities in these pediatric patients.

Entities:  

Mesh:

Year:  1988        PMID: 2463569     DOI: 10.1111/j.1540-8159.1988.tb06331.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Superior vena cava and innominate vein dimensions in growing children : an aid for interventional devices and transvenous leads.

Authors:  Sanjeev Sanjeev; Peter P Karpawich
Journal:  Pediatr Cardiol       Date:  2006-07-06       Impact factor: 1.655

2.  Implantable diagnostic and therapeutic devices in children.

Authors:  T-N Le; S C Gouw; T M Hoorntje; N Sreeram
Journal:  Neth Heart J       Date:  2002-11       Impact factor: 2.380

3.  Longitudinal Outcomes of Epicardial and Endocardial Pacemaker Leads in the Adult Fontan Patient.

Authors:  Geoffrey D Huntley; Abhishek J Deshmukh; Carole A Warnes; Suraj Kapa; Alexander C Egbe
Journal:  Pediatr Cardiol       Date:  2018-06-14       Impact factor: 1.655

4.  Endocardial and epicardial steroid lead pacing in the neonatal and paediatric age group.

Authors:  F Udink ten Cate; J Breur; N Boramanand; J Crosson; A Friedman; J Brenner; E Meijboom; N Sreeram
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 5.  Pacing device therapy in infants and children: a review.

Authors:  Daiji Takeuchi; Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-10-27       Impact factor: 1.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.